Cart
sales@molnova.com
Home - Products - Others - Other Targets - Antiproliferative agent-36

Antiproliferative agent-36

CAS No. 193828-76-1

Antiproliferative agent-36( —— )

Catalog No. M37316 CAS No. 193828-76-1

Antiproliferative agent-36 is a broad-spectrum anticancer benzothiazolylhydrazone-derived compound that inhibits cell proliferation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 321 In Stock
10MG 459 In Stock
25MG 718 In Stock
50MG 958 In Stock
100MG 1274 In Stock
200MG 1721 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Antiproliferative agent-36
  • Note
    Research use only, not for human use.
  • Brief Description
    Antiproliferative agent-36 is a broad-spectrum anticancer benzothiazolylhydrazone-derived compound that inhibits cell proliferation.
  • Description
    Antiproliferative agent-36 (compound 8i) is a benzothiazolyl hydrazones derived compound with antiproliferative activity. Antiproliferative agent-36 has a broad-spectrum anticancer activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    193828-76-1
  • Formula Weight
    269.33
  • Molecular Formula
    C13H11N5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(/N=C(\C)/C=1C=CN=CN1)C2=NC=3C(S2)=CC=CC3
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. J Easmon, et al. (1997). Thiazolyl and benzothiazolyl hydrazones derived from α-(N)-acetylpyridines and diazines: synthesis, antiproliferative activity and CoMFA studies. , 32(5), 397-408.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Linzagolix

    Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis.

  • Palomid 529

    Palomid 529 has been used in trials studying the treatment of Age-Related Macular Degeneration.

  • Human IgG1 Control

    Human IgG1 Control was purified from Human serum by chromatography.Human IgG1 Control can be used as a Control, standard, blocking agent, or coating protein in a variety of experiments, including ELISA, Western and blotting, immunoprecipitation, and immunoelectrophoresis.Human IgG1 Control can also be used as an antigen or ligand in immunochemical conjugate reactions.

Sign In Join Free